Latest Headlines
More frequent surveillance reduces colon cancer risk in Lynch syndrome families
Radiation can be avoided in early Hodgkin's lymphoma
Vaginal dilation does not prevent damage from radiotherapy
Robotic prostatectomy curbs blood loss
MRI alone sufficient screen in women with familial risk of breast cancer
NEWS PROVIDED BY 
VIEW ALL NEWSRoche says Avastin restriction removed
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said the European Medicines Agency has removed a restriction on the label that prevented the use of Avastin in some patients whose cancer had spread to their brain.
Roche said the agency made its decision following a review of a number of analyses from clinical trials, as well as a safety database generated through use of Avastin over more than a decade.
Avastin is approved for the treatment of advanced-stage colorectal cancer, breast cancer, lung cancer and renal cell cancer.
Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
NEWS PROVIDED BY
TEXT SIZE 